The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Open accessAbstract
BACKGROUND: Glioblastoma multiforme (GBM) is the most frequent malignant brain tumor in adults, and its prognosis remains dismal despite intensive research and therapeutic advances. Diagnostic biomarkers would be clinically meaningful to allow for early detection of the tumor and for those cases in which surgery is contraindicated or biopsy results are inconclusive. Recent findings show that GBM cells release microvesicles that contain a select subset of cellular proteins and RNA. The aim of this hypothesis-generating study was to assess the diagnostic potential of miRNAs found in microvesicles isolated from the serum of GBM patients. METHODS: To control disease heterogeneity, we used patients with newly diagnosed GBM. In the discovery stage, PCR-based TaqMan Low Density Arrays followed by individual quantitative reverse transcriptase polymerase chain reaction were used to test the differences in the miRNA expression levels of serum microvesicles among 25 GBM patients and healthy controls paired by age and sex. The detected noncoding RNAs were then validated in another 50 GBM patients. RESULTS: We found that the expression levels of 1 small noncoding RNA (RNU6-1) and 2 microRNAs (miR-320 and miR-574-3p) were significantly associated with a GBM diagnosis. In addition, RNU6-1 was consistently an independent predictor of a GBM diagnosis. CONCLUSIONS: Altogether our results uncovered a small noncoding RNA signature in microvesicles isolated from GBM patient serum that could be used as a fast and reliable differential diagnostic biomarker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedNon-coding RNA production by RNA polymerase III is implicated in cancer
Marshall, L., & White, R. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2539 · Cited by 122
RetractedThe Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
ROCR: visualizing classifier performance in R
Sing, T., Sander, O., Beerenwinkel, N., & Lengauer, T. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti623 · Cited by 3,200
Exosomes: Extracellular organelles important in intercellular communication
Mathivanan, S., Ji, H., & Simpson, R. J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.06.006 · Cited by 2,537
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., & Kloecker, G. H. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.006 · Cited by 1,262
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences
Balaj, L., Lessard, R., Dai, L., Cho, Y.-J., Pomeroy, S. L., Breakefield, X. O., & Skog, J. (2011) · Nature Communications · doi:10.1038/ncomms1180 · Cited by 1,187
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
A novel and universal method for microRNA RT-qPCR data normalization
Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., & Vandesompele, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-6-r64 · Cited by 1,079 · cited 1×
“MiRNA expression normalization was performed following 2 different approaches: using the RNU48 endogenous control and using median normalization analysis.(25) Both normalization methods identified almost the same miRNAs deregulated with a significant FDR supporting each other.”
MethodBlood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Pritchard, C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., Tait, J. F., & Tewari, M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0370 · Cited by 879 · cited 1×
“However, we cannot rule out that miR-574-3p detection in serum is due to secretion of myeloid cells rather than tumor cells.(48) One limitation of the present report is the lack of a control group of patients with other CNS disorders, such as cerebrovascular diseases, multiple sclerosis, and abscesses, and other brain…”
BackgroundProtein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D. D., Carter, B. S., Hochberg, F. H., Breakefield, X. O., Weissleder, R., & Lee, H. (2012) · Nature Medicine · doi:10.1038/nm.2994 · Cited by 759
Real-time PCR quantification of precursor and mature microRNA
Schmittgen, T. D., Lee, E. J., Jiang, J., Sarkar, A., Yang, L., Elton, T. S., & Chen, C. (2008) · Methods · doi:10.1016/j.ymeth.2007.09.006 · Cited by 616
Patterns of Contrast Enhancement in the Brain and Meninges
Smirniotopoulos, J. G., Murphy, F. M., Rushing, E. J., Rees, J. H., & Schroeder, J. W. (2007) · RadioGraphics · doi:10.1148/rg.272065155 · Cited by 502
Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E., Watkins, S., & Whiteside, T. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1010.11.3 · Cited by 497
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjøt, L., Wiuf, C., Sørensen, F. J., Kruhøffer, M., Laurberg, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6110 · Cited by 492
Proteomic and immunologic analyses of brain tumor exosomes
Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., Mitchell, D. A., & Bigner, D. D. (2009) · The FASEB Journal · doi:10.1096/fj.08-122184 · Cited by 429
Exosome Isolation for Proteomic Analyses and RNA Profiling
Taylor, D. D., Zacharias, W., & Gercel-Taylor, C. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-068-3_15 · Cited by 391
Teplyuk, N. M., Mollenhauer, B., Gabriely, G., Giese, A., Kim, E., Smolsky, M., Kim, R. Y., Saria, M. G., Pastorino, S., Kesari, S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos074 · Cited by 302
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
Bronisz, A., Godlewski, J., Wallace, J. A., Merchant, A. S., Nowicki, M. O., Mathsyaraja, H., Srinivasan, R., Trimboli, A. J., Martin, C. K., Li, F., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2396 · Cited by 270
Gui, J., Tian, Y., Wen, X., Zhang, W., Zhang, P., Gao, J., Run, W., Tian, L., Jia, X., & Gao, Y. (2011) · Clinical Science · doi:10.1042/cs20100297 · Cited by 222
Tumor-derived exosomes: a new source of tumor rejection antigens
André, F., Schartz, N. E. C., Chaput, N., Flament, C., Raposo, G., Amigorena, S., Angevin, E., & Zitvogel, L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00384-5 · Cited by 220
Repression of RNA polymerase III transcription by the retinoblastoma protein
White, R. J., Trouche, D., Martin, K., Jackson, S. P., & Kouzarides, T. (1996) · Nature · doi:10.1038/382088a0 · Cited by 204
A specific miRNA signature in the peripheral blood of glioblastoma patients
Roth, P., Wischhusen, J., Happold, C., Chandran, P. A., Hofer, S., Eisele, G., Weller, M., & Keller, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07307.x · Cited by 200
Yang, C., Wang, C., Chen, X., Chen, S., Zhang, Y., Zhi, F., Wang, J., Li, L., Zhou, X., Li, N., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27657 · Cited by 191
Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma
Rao, S. A., Santosh, V., & Somasundaram, K. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.135 · Cited by 179
Baraniskin, A., Nöpel‐Dünnebacke, S., Ahrens, M., Jensen, S. G., Zöllner, H., Maghnouj, A., Wos, A., Mayerle, J. V., Munding, J. B., Kost, D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27791 · Cited by 159
Houalı, K., Wang, X., Shimizu, Y., Djennaoui, D., Nicholls, J. M., Fiorini, S., Bouguermouh, A., & Ooka, T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2945 · Cited by 141
Reproducible Research: A Bioinformatics Case Study
Gentleman, R. C. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1034 · Cited by 137
MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived Exosomes
Camacho, L., Guerrero, P. A., & Marchetti, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073790 · Cited by 123
Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients
Appaiah, H. N., Goswami, C. P., Mina, L. A., Badve, S., Sledge, G. W., Liu, Y., & Nakshatri, H. (2011) · Breast Cancer Research · doi:10.1186/bcr2943 · Cited by 105
Bergmann, C., Strauss, L., Wieckowski, E. U., Czystowska, M., Albers, A. E., Wang, Y., Zeidler, R., Lang, S., & Whiteside, T. L. (2008) · Head & Neck · doi:10.1002/hed.20968 · Cited by 102
MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas
Hermansen, S. K., Dahlrot, R. H., Nielsen, B. S., Hansen, S., & Kristensen, B. W. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0992-3 · Cited by 89
Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p
Su, Y., Ni, Z., Wang, G., Cui, J., Wei, C., Wang, J., Yang, Q., Xu, Y., & Li, F. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.05.016 · Cited by 68
Tatarano, S., Chiyomaru, T., Kawakami, K., Enokida, H., Yoshino, H., Hidaka, H., Nohata, N., Yamasaki, T., Gotanda, T., Tachiwada, T., et al. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1294 · Cited by 62
Role of the snRNAs in spliceosomal active site
Valadkhan, S. (2010) · RNA Biology · doi:10.4161/rna.7.3.12089 · Cited by 58
Inhibition of U6 snRNA Transcription by PTEN
Cabarcas‐Petroski, S. (2010) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2010.114.125 · Cited by 25
Part B—MicroRNAs: MicroRNA methods
Schmittgen, T. D. (2007) · Methods · doi:10.1016/j.ymeth.2007.11.013 · Cited by 9
Cited by
MicroRNAs in cancer: biomarkers, functions and therapy
Hayes, J., Peruzzi, P. P., & Lawler, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.005 · Cited by 2,049
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells.
Squadrito, M. L., Baer, C., Burdet, F., Maderna, C., Gilfillan, G. D., Lyle, R., Ibberson, M., & De Palma, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.035 · Cited by 604
Exosomes─Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics
Tenchov, R., Sasso, J. M., Wang, X., Liaw, W.-S., Chen, C.-A., & Zhou, Q. A. (2022) · ACS Nano · doi:10.1021/acsnano.2c08774 · Cited by 604
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Berindan‐Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21244 · Cited by 522
Metadata
- Authors
- Manterola, L., Guruceaga, E., Pérez-Larraya, J. G., González-Huarriz, M., Jauregui, P., Tejada, S., Diez-Valle, R., Segura, V., Samprón, N., Barrena, C., Ruiz, I., Agirre, A., Ayuso, Á., Rodríguez, J., González, Á., Xipell, E., Matheu, A., López de Munain, A., Tuñón, T., Zazpe, I., García-Foncillas, J., Paris, S., Delattre, J. Y., & Alonso, M. M.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-16
- Volume
- 16
- Issue
- 4
- Pages
- 520-527
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2096712415
- Cited by
- 345
- References
- 48
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.